Canada markets open in 4 hours 38 minutes

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.5900+0.0100 (+0.39%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 97.93M
Enterprise Value 45.44M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.92
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.14

Trading Information

Stock Price History

Beta (5Y Monthly) 1.74
52-Week Change 355.09%
S&P500 52-Week Change 323.57%
52 Week High 34.7500
52 Week Low 31.5800
50-Day Moving Average 32.7609
200-Day Moving Average 32.7796

Share Statistics

Avg Vol (3 month) 337.57k
Avg Vol (10 day) 313.96k
Shares Outstanding 537.96M
Implied Shares Outstanding 638.28M
Float 823.82M
% Held by Insiders 126.65%
% Held by Institutions 121.98%
Shares Short (Apr 15, 2024) 4175.43k
Short Ratio (Apr 15, 2024) 43.11
Short % of Float (Apr 15, 2024) 40.74%
Short % of Shares Outstanding (Apr 15, 2024) 40.46%
Shares Short (prior month Mar 15, 2024) 4212.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 15, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Nov 15, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-30.02%
Return on Equity (ttm)-46.77%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.24M
Net Income Avi to Common (ttm)-19.38M
Diluted EPS (ttm)-0.6000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)52.9M
Total Cash Per Share (mrq)1.39
Total Debt (mrq)400k
Total Debt/Equity (mrq)0.78%
Current Ratio (mrq)19.27
Book Value Per Share (mrq)1.35

Cash Flow Statement

Operating Cash Flow (ttm)-18.73M
Levered Free Cash Flow (ttm)-11.45M